Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,349 | 199 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $594.23 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $425.82 | 17 | $0 (2024) |
| PFIZER INC. | $388.82 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $277.62 | 11 | $0 (2024) |
| Amgen Inc. | $265.67 | 12 | $0 (2024) |
| Medtronic, Inc. | $239.65 | 6 | $0 (2024) |
| Esperion Therapeutics, Inc. | $233.37 | 14 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $199.80 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $197.61 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $192.02 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $875.64 | 38 | Novartis Pharmaceuticals Corporation ($154.33) |
| 2023 | $1,720 | 72 | Novartis Pharmaceuticals Corporation ($215.35) |
| 2022 | $1,308 | 66 | Novartis Pharmaceuticals Corporation ($178.92) |
| 2021 | $445.25 | 23 | E.R. Squibb & Sons, L.L.C. ($52.33) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/14/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/27/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $22.22 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $40.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Not Applicable | ||||||
| 05/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $25.90 | General |
| Category: Cardiology | ||||||
| 05/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: DIABETES | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $31.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Vascular | ||||||
| 04/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: DIABETES | ||||||
| 04/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 27 | $4,680 | $1,463 |
| 2022 | 2 | 36 | 36 | $7,167 | $2,019 |
| 2021 | 6 | 220 | 229 | $42,762 | $13,328 |
| 2020 | 7 | 566 | 678 | $108,938 | $35,940 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,140 | $1,317 | 31.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $540.00 | $145.96 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,555 | $1,851 | 28.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $612.00 | $168.21 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 57 | $13,225 | $3,883 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 63 | $10,080 | $3,344 | 33.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $9,315 | $3,007 | 32.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 22 | 23 | $5,290 | $1,591 | 30.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 21 | 22 | $3,520 | $1,119 | 31.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 37 | 37 | $1,332 | $384.65 | 28.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 228 | 293 | $67,390 | $20,427 | 30.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 120 | 144 | $23,040 | $7,341 | 31.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 54 | 61 | $9,225 | $4,255 | 46.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 56 | 64 | $5,312 | $2,700 | 50.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 75 | 81 | $2,916 | $937.64 | 32.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 22 | 24 | $912.00 | $223.25 | 24.5% |
| 93041 | Tracing of electrical activity of the heart using 1-3 leads | Office | 2020 | 11 | 11 | $143.00 | $55.57 | 38.9% |
About Robin Whitman, NP
Robin Whitman, NP is a Nurse Practitioner healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740205707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robin Whitman, NP has received a total of $4,349 in payments from pharmaceutical and medical device companies, with $875.64 received in 2024. These payments were reported across 199 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,349).
As a Medicare-enrolled provider, Whitman has provided services to 849 Medicare beneficiaries, totaling 970 services with total Medicare billing of $52,750. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location La Jolla, CA
- Active Since 07/12/2006
- Last Updated 02/25/2010
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1740205707
Products in Payments
- ELIQUIS (Drug) $580.84
- LEQVIO (Drug) $482.60
- VERQUVO (Drug) $425.82
- Repatha (Biological) $265.67
- NEXLETOL (Drug) $233.37
- LINQ II (Device) $215.69
- Arcalyst (Drug) $199.80
- XARELTO (Drug) $197.61
- LifeVest (Device) $167.42
- Barostim Neo System (Device) $153.70
- CARTO 3 (Device) $135.05
- JARDIANCE (Drug) $130.47
- ENTRESTO (Drug) $111.63
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $109.66
- FARXIGA (Drug) $89.09
- Vascepa (Drug) $66.84
- MITRACLIP (Device) $58.70
- BRILINTA (Drug) $57.45
- INJECTAFER (Drug) $53.84
- ONPATTRO (Drug) $50.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in La Jolla
Sherrie Gould, N.p, N.P
Nurse Practitioner — Payments: $192,225
Katie Lynn Bordonaro, Agpcnp, AGPCNP
Nurse Practitioner — Payments: $43,065
Noelle Simms, Dnp, Fnp-C, DNP, FNP-C
Nurse Practitioner — Payments: $9,975
Archana Ajmera, Rn, Msn, Aprn-Bc, RN, MSN, APRN-BC
Nurse Practitioner — Payments: $3,545
Ms. Stephanie Tomicich, Np, NP
Nurse Practitioner — Payments: $2,833
Cheng Sun, Anp, ANP
Nurse Practitioner — Payments: $2,812